Why DexCom (DXCM) Dipped More Than Broader Market Today
DexCom (DXCM) reachead $122.59 at the closing of the latest trading day, reflecting a -0.41% change compared to its last close.
Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?
Here is how DexCom (DXCM) and Exscientia PLC Sponsored ADR (EXAI) have performed compared to their sector so far this year.
Is DexCom (DXCM) a Solid Growth Stock? 3 Reasons to Think "Yes"
DexCom (DXCM) possesses solid growth attributes, which could help it handily outperform the market.
Integra Gains From New Product Launches, Mounting Costs Ail
Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.
DexCom (DXCM) is an Incredible Growth Stock: 3 Reasons Why
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Is DexCom the Next Big Growth Stock?
DexCom's valuation suggests that investors have very high expectations for growth. It's in the process of penetrating the U.S and European markets, among others.
DexCom CF0: GLP-1s and continuous glucose monitoring are companion therapies
Jereme Sylvain, CFO at DexCom joins Bloomberg Radio to discuss DexCom's earnings and financial outlook. -------- Get more on The Tape Podcast On Apple: http://bit.ly/3YrBfOi On Spotify: http://bit....
3 Healthcare Stocks Getting Help From the Aging Population
A record number of Americans are now turning 65, Forbes recently reported, amid tens of millions of Baby Boomers. In fact, according to one report, 76.4 million Baby Boomers are living in America c...
2 Growth Stocks That Could Help Set You Up for Life
Healthcare and e-commerce are two massive, lucrative industries that aren't slowing down. DexCom is riding on a wave of profits and cash from its latest launches.
3 Reasons Growth Investors Will Love DexCom (DXCM)
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
What Makes DexCom (DXCM) a New Buy Stock
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Dexcom stock climbs as worries surrounding weight-loss drugs fades
CNBC's Angelica Peebles joins 'Closing Bell Overtime' to take a closer look at stock movers in the healthcare sector.
Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be
The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.
DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook
DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Related Companies